Cargando…
Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience
OBJECTIVES: Biomarkers for invasive fungal disease (IFD) have been shown to reduce antifungal prescriptions in neutropaenic haemato-oncology patients. Our study aimed to assess the real-life impacts of introducing a novel biomarker-based pathway, incorporating serum galactomannan and Aspergillus PCR...
Autores principales: | Martinelli, Anthony W., Wright, Callum B., Lopes, Marta S., Swayne, Rosemary L., Krishnamurthy, Pramila, Crawley, Charles, Uttenthal, Ben, Follows, George, Babar, Judith, Aliyu, Sani H., Enoch, David A., Sander, Clare R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613179/ https://www.ncbi.nlm.nih.gov/pubmed/35819894 http://dx.doi.org/10.1099/jmm.0.001564 |
Ejemplares similares
-
Haemato-oncology and burnout: an Italian survey
por: Bressi, C, et al.
Publicado: (2008) -
Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey
por: Bobeff, Katarzyna, et al.
Publicado: (2023) -
The importance of cleanrooms for the treatment of haemato-oncological patients
por: Holý, Ondřej, et al.
Publicado: (2012) -
Empirical antimicrobial treatment in haemato-/oncological patients with neutropenic sepsis
por: Vossen, Matthias Gerhard, et al.
Publicado: (2018) -
Leukopenia predicts outcome in haemato-oncological patients requiring intensive care
por: Margarson, MP, et al.
Publicado: (2001)